Clinical Cancer Research Meeting Calendar Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hahtola, S.
Right arrow Articles by Ranki, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahtola, S.
Right arrow Articles by Ranki, A.
Clinical Cancer Research Vol. 12, 4812-4821, August 15, 2006
© 2006 American Association for Cancer Research


Human Cancer Biology

Th1 Response and Cytotoxicity Genes Are Down-Regulated in Cutaneous T-Cell Lymphoma

Sonja Hahtola1, Soile Tuomela2,3, Laura Elo2,4, Tiina Häkkinen2,{dagger}, Leena Karenko1, Boguslaw Nedoszytko5, Hannele Heikkilä1, Ulpu Saarialho-Kere1, Jadwiga Roszkiewicz5, Tero Aittokallio2,4, Riitta Lahesmaa2 and Annamari Ranki1

Authors' Affiliations: 1 Department of Dermatology, Helsinki University Central Hospital, Helsinki, Finland; 2 Turku Centre for Biotechnology, University of Turku and Åbo Akademi University; 3 Turku Graduate School of Biomedical Sciences; 4 Department of Mathematics, University of Turku, Turku, Finland; and 5 Department of Dermatology, Medical University of Gdansk, Gdansk, Poland

Requests for reprints: Annamari Ranki, Department of Dermatology, Skin and Allergy Hospital, Helsinki University Hospital, P.O. Box 160, 00029 HUS Helsinki, Finland. Phone: 358-947186300; Fax: 358-947186500; E-mail: Annamari.Ranki{at}hus.fi.

Purpose: Increased production of Th2 cytokines characterizes Sezary syndrome, the leukemic form of cutaneous T-cell lymphomas (CTCL). To identify the molecular background and to study whether shared by the most common CTCL subtype, mycosis fungoides, we analyzed the gene expression profiles in both subtypes.

Experimental Design: Freshly isolated cells from 30 samples, representing skin, blood, and enriched CD4+ cell populations of mycosis fungoides and Sezary syndrome, were analyzed with Affymetrix (Santa Clara, CA) oligonucleotide microarrays, quantitative PCR, or immunohistochemistry. The gene expression profiles were combined with findings of comparative genomic hybridization of the same samples to identify chromosomal changes affecting the aberrant gene expression.

Results: We identified a set of Th1-specific genes [e.g., TBX21 (T-bet), NKG7, and SCYA5 (RANTES)] to be down-regulated in Sezary syndrome as well as in a proportion of mycosis fungoides samples. In both Sezary syndrome and mycosis fungoides blood samples, the S100P and LIR9 gene expression was up-regulated. In lesional skin, IL7R and CD52 were up-regulated. Integration of comparative genomic hybridization and transcriptomic data identified chromosome arms 1q, 3p, 3q, 4q, 12q, 16p, and 16q as likely targets for new CTCL-associated gene aberrations.

Conclusions: Our findings revealed several new genes involved in CTCL pathogenesis and potential therapeutic targets. Down-regulation of a set of genes involved in Th1 polarization, including the major Th1-polarizing factor, TBX21, was for the first time associated with CTCL. In addition, a plausible explanation for the proliferative response of CTCL cells to locally produced interleukin-7 was revealed.




This article has been cited by other articles:


Home page
BloodHome page
E. Kennah, A. Ringrose, L. L. Zhou, S. Esmailzadeh, H. Qian, M.-w. Su, Y. Zhou, and X. Jiang
Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells
Blood, May 7, 2009; 113(19): 4646 - 4655.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. F. Chong, A. J. Wilson, H. M. Gibson, M. S. Hafner, Y. Luo, C. J. Hedgcock, and H. K. Wong
Immune Function Abnormalities in Peripheral Blood Mononuclear Cell Cytokine Expression Differentiates Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Clin. Cancer Res., February 1, 2008; 14(3): 646 - 653.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.